Search Results

Displaying Results 1-12 of 12 "'ETB'"

Apr 30, 2026, 09:00 ET African Private Sector Leaders Convene in Addis Ababa to Unlock Capital and Scale SDG Delivery

customers across trade, services (finance, health, transport and tourism), manufacturing, construction and agriculture. The platform has disbursed over ETB 52 billion (USD 400 million) to nearly 3 million customers, achieving 80% youth and 80% women inclusion, creating approximately 2.7 million jobs, and

More news about: United Nations Global Compact


Apr 30, 2026, 09:00 ET African Private Sector Leaders Convene in Addis Ababa to Unlock Capital and Scale SDG Delivery

customers across trade, services (finance, health, transport and tourism), manufacturing, construction and agriculture. The platform has disbursed over ETB 52 billion (USD 400 million) to nearly 3 million customers, achieving 80% youth and 80% women inclusion, creating approximately 2.7 million jobs, and

More news about: United Nations Global Compact


Apr 21, 2026, 06:47 ET Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026

operating performance measures that exclude special items such as restructuring and integration charges, amortization expense, excess tax benefits ("ETB") associated with stock-based compensation, gains and losses associated with changes in the carrying value of our strategic investments and other items.Non-GAAP

More news about: Quest Diagnostics


Feb 10, 2026, 06:47 ET Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share

operating performance measures that exclude special items such as restructuring and integration charges, amortization expense, excess tax benefits ("ETB") associated with stock-based compensation, gains and losses associated with changes in the carrying value of our strategic investments, impairment charges

More news about: Quest Diagnostics


Dec 11, 2025, 08:41 ET Energy Toolbase Launches Energy Storage Partnership with Sungrow to Support PowerStack 255CS and PowerTitan 2.0

STUART, Fla., Dec. 11, 2025 /PRNewswire/ -- Energy Toolbase (ETB) has announced an energy storage partnership with

More news about: Energy Toolbase


Dec 03, 2025, 08:34 ET Energy Toolbase and BPi Implement Energy Storage and Control System at Korbel Winery

facility. Through Acumen AI's dynamic economic dispatch strategy, ETB Controller optimizes the battery's operation in real time to determine the most cost-effective dispatch strategy and maximize economic value without manual intervention. ETB Controller manages energy flow to shave the site's peak demand,

More news about: Energy Toolbase


Nov 19, 2025, 07:53 ET Economic Times GCC Conclave Returns With Expanded Agenda and Inaugural Awards

"India's GCC ecosystem is no longer just supporting global enterprises—it's actively shaping their future," said Amit Kumar Gupta, Business Head, ETB2B. "This conclave will spotlight the leaders and innovations driving that transformation, while our inaugural awards celebrate the visionaries making

More news about: The Economic Times


Oct 21, 2025, 06:45 ET Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

operating performance measures that exclude special items such as restructuring and integration charges, amortization expense, excess tax benefits ("ETB") associated with stock-based compensation, gains and losses associated with changes in the carrying value of our strategic investments, impairment charges

More news about: Quest Diagnostics


Sep 05, 2025, 08:00 ET Idorsia to collaborate with two leading academic medical centers to launch IMPACT-HTN - a US initiative to transform care for patients with difficult-to-control hypertension

aprocitentanAprocitentan is Idorsia's once-daily, orally active, dual endothelin receptor antagonist, which inhibits the binding of ET-1 to ETA and ETB receptors. Aprocitentan is approved as TRYVIO® in the US for the treatment of systemic hypertension in combination with other antihypertensives

More news about: Idorsia Pharmaceuticals Ltd.


Aug 26, 2025, 08:01 ET Hasselblad's X2D II 100C, 35-100mm f/2.8-4 Lens Bring High-Speed AF to Medium Format; First Look YouTube Video X2D II Camera, Now in Stock at B&H

https://youtu.be/pyRqoY8ETB4 Learn all about Hasselblad X2D II Camera and 35-100mm Lens at Explora

More news about: B&H Photo


Jul 22, 2025, 06:47 ET Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025

operating performance measures that exclude special items such as restructuring and integration charges, amortization expense, excess tax benefits ("ETB") associated with stock-based compensation, gains and losses associated with changes in the carrying value of our strategic investments, impairment charges

More news about: Quest Diagnostics


Jun 25, 2025, 20:38 ET BioCity's ETA-Selective Antagonist SC0062 Granted Breakthrough Therapy Designation in China for Diabetic Kidney Disease with Albuminuria

a novel and unique ETA  antagonist characterized by its high selectivity for ETA compared to the endothelin receptor B (ETB). Its strong selectivity for ETA suggests that it has greater potential than non-selective endothelin receptor antagonists for slowing

More news about: BioCity Biopharma


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.